Table 1.
Preoperative variables of all RALP patients with and without preoperative mpMRI.
Fig 1.
Additive predictive value of any adverse RP findings by mpMRI in ROC-AUC and Decision curve analysis (DCA) for a-b) clinical characteristics; c-d) Partin table estimates; e-f) MSKCC nomogram parameters.
Table 2.
Regression model summaries: Prediction of any adverse findings at prostatectomy.
Fig 2.
BCR free survival probability–a) Kaplan-Meier survival analysis for CAPRA risk groups; b) Survival plots for mpMRI any adverse finding (ANY) versus organ confined (OC) in the CAPRA group; c) Survival plot for mpMRI any adverse finding (ANY) versus organ confined (OC) in the CAPRA high risk group.
Fig 3.
BCR free survival probability–a) Kaplan-Meier survival analysis for MSKCC BCR free survival at 80% after 3 years; b) Survival plot for mpMRI any adverse finding (ANY) versus organ confined (OC) in the MSKCC BCR high risk group (<80%).